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Epidermolysis bullosa simplex is a hereditary skin
blistering disorder caused by mutations in the
KRT5 or KRT14 genes. More than 50 different
mutations have been described so far. These, and
reports of other keratin gene mutations, have
highlighted the existence of mutation ``hotspots''
in keratin proteins at which sequence changes are
most likely to be detrimental to protein function.
Pathogenic mutations that occur outside these hot-
spots are usually associated with less severe disease
phenotypes. We describe a novel K5 mutation
(V186L) that produces a conservative amino acid
change (valine to leucine) at position 18 of the 1A
helix. The phenotype of this case is unexpectedly
severe for the location of the mutation, which lies
outside the consensus helix initiation motif muta-
tion hotspot, and other mutations at this position
have been associated in Weber±Cockayne (mild)
epidermolysis bullosa simplex only. The mutation
was con®rmed by mismatch-allele-speci®c poly-
merase chain reaction and the entire KRT5 coding
region was sequenced, but no other changes were
identi®ed. De novo K5/K14 (mutant and wild-type)
®lament assembly in cultured cells was studied to
determine the effect of this mutation on ®lament
polymerization and stability. A computer model of
the 1A region of the K5/K14 coiled-coil was gen-
erated to visualize the structural impact of this
mutation and to compare it with an analogous
mutation causing mild disease. The results show a
high level of concordance between genetic, cell
culture and molecular modeling data, suggesting
that even a conservative substitution can cause
severe dysfunction in a structural protein, depend-
ing on the size and structure of the amino acid
involved. Key words: coiled-coil/epidermolysis bullosa
simplex/intermediate ®laments. J Invest Dermatol
116:964±969, 2001
K
eratins are a diverse group of structural proteins that
polymerize to give keratin intermediate ®laments.
They are expressed in all epithelial cells, showing
both tissue and cell type speci®city. According to
their physical and chemical properties, keratins are
divided into type I (K9±K20) or type II (K1±K8) proteins. The
keratin heterodimer (one type I keratin and its corresponding type
II partner) is the basic structural unit of the ®lament. A
characteristic of all intermediate ®lament proteins is the central
a-helical rod domain (containing 310±360 amino acid residues)
which is divided into four helices (1A, 1B, 2A, and 2B) by three
short nonhelical linker domains (L1, L12, and L2). More than 160
keratin mutations have been discovered that are linked to a disease
phenotype and two principal ``hotspot'' regions have been
determined, each consisting of 10±15 residues located at the
extremities of the a-helical rod domain of the proteins.
In epidermolysis bullosa simplex (EBS), an inherited blistering
disorder of the skin, a relationship has been observed between
the mutation position (in K5 and K14) and clinical severity
[from mild Weber±Cockayne (EBS-WC) to severe Dowling±
Meara (EBS-DM)]. Cases of EBS-K (KoÈbner type EBS) and
EBS±DM, the more severe forms of EBS, are mainly due to
mutations lying within the two hotspot regions that encode the
helix initiation and termination peptide sequences at the ends of
the rod domains (Bonifas et al, 1991; Coulombe et al, 1991;
Yamanishi et al, 1994; Chen et al, 1995; Stephens et al, 1995,
1997; Nomura et al, 1996; Shemanko et al, 1998). Milder forms
of disease were found to be linked to four other cluster sites
outside the helix boundary motifs (Rugg et al, 1993; Chan et al,
1994; Lane, 1994; Chen et al, 1995; MuÈller et al, 1998; Liovic
et al 2000). We recently, however, identi®ed a K5 mutation1
(N177S) in the helix initiation motif that gives rise to a mild
WC disease phenotype. In addition, some other mutations
outside the hotspots have been reported to cause an extensive
EBS phenotype (Hovnanian et al, 1993; Humphries et al, 1993,
1996; Galligan et al, 1998).
Here we present a novel mutation in the 1A helix of K5, V186L,
identi®ed in an EBS family with a severe phenotype. This mutation
lies at the same position in the helix 1A domain of K5 as a
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previously reported mutation1 in its partner keratin K14, V133L,
which was associated with a much milder disease. As the K5
mutation results in a worse clinical phenotype than the analogous
mutation in K14, we compared the effects of the two mutations on
intracellular ®laments by transfection assays, and on the predicted
three-dimensional structure of the 1A domain using computer-
generated molecular models. The results demonstrate the signi®-
cant effect a conservative substitution can have on protein function.
Depending on the size and structure of the amino acid involved and
the local sequence context, a mutation can lead to the development
of different disease phenotypes.
MATERIALS AND METHODS
Patients A skin biopsy of one affected individual from a family with a
three-generation history (Fig 1A) of EBS was taken for histopathology
and electron microscopy. This revealed cytolysis within the basal cell
layer of the epidermis in affected skin. The 2 y old affected girl, her
father, and grandfather were all examined by us. The clinical appearance
of two of the patients is exempli®ed in Fig 1(B±E). Reportedly, all
affected individuals in the family had widespread blistering on large areas
of the trunk, neck, cheek, and extremities from early childhood and
onwards. This was still the case for the girl and her paternal aunt, but the
father and grandfather had improved spontaneously at puberty with only
minor blistering activity remaining on the sides of the palms and soles,
and occasionally on the trunk when traumatized. The palmar blisters
sometimes become large and tender and are usually surrounded by a red
halo of in¯ammation without signs of bacterial infection (see Fig 1B).
There is no milia formation. The girl's blistering activity also extends to
the dorsum of the hands and feet (Fig 1C), the perineum and gluteal
skin (Fig 1D, E), and the lips, cheeks, and side of the neck. She has
occasional feeding problems due to erosions inside the mouth. Healing
of the blisters is always without scarring and only few milia have
appeared on the dorsum of the feet (see Fig 1C). Over an observation
period of 2 y she has shown no signs of a spontaneous improvement of
the blistering, but her nails have remained unaffected. The blistering
activity usually gets worse in the summer time and in a hot, humid
climate. Owing to the generalized blistering in childhood, the family was
diagnosed as having EBS-K.
Genomic DNA isolation Blood samples were taken from two
affected and an unaffected individual and genomic DNA was extracted
by standard techniques (Nucleon II Kit, Scotlab Ltd, Cambridge, U.K.).
In addition, genomic DNA from 50 healthy individuals were used as
controls.
Automated DNA sequencing The 1A region of K5 was ampli®ed
using speci®c oligonucleotide pairs (KRT5 exon 1: HK5p5 5¢-
GCTGAGCTCTGTTCTCTCCAGCAC-3¢ and HK5pA2r (Stephens et
al, 1997) 5¢-CCTTCTTTCTCTCTCTTTGGC-3¢; KRT5 exon 2:
HK5p14 5¢-GCCAAAGAGAGAGAAAGAAGG-3¢ and HK5p15r 5¢-
GTCCATGGAAGGTATATCCTC-3¢. Polymerase chain reaction
(PCR) was performed with an initial ``hot start'' (7 min denaturation at
94°C), followed by 30 cycles of: 30 s at 94°C, 50 s at 60°C, and 3 min
at 72°C and a ®nal 15 min extension at 72°C. An aliquot (4 ml) of each
PCR product was analyzed on a 1.5% agarose gel and the remainder
used for sequencing. Prior to sequencing, PCR products were puri®ed
with Qiaquick PCR puri®cation kit (Qiagen, Crawley, U.K.).
Subsequently, 100 ng of puri®ed product was used per sequencing
reaction according to the Big Dye Terminator (Perkin Elmer, Foster
City, CA) chemistry and run on an ABI 310 genetic analyzer. The
sequencing primers for exons 1 and 2 of KRT5 (K5 1A region) were
HK5pA2r and HK5p15r, respectively.
Figure 1. The EBS-K case with the K5V186L
mutation. (A) Family pedigree. Affected family
members are present in all three generations.
Family members investigated in this study are
marked with a star. Clinical features of the father's
hand (B) and his 2 y old daughter's foot, buttocks,
and perineum (C±E) showing blisters of varying
sizes and the red halo surrounding them.
1Liovic M, Marks R, Komel R, Bowden PE: Novel mutations in the 1A
helical domain of K5 and K14 are involved in a mild epidermolysis bullosa
simplex (EBS) phenotype. J Invest Dermatol 109:405, 1997 (Abstr.)
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Mismatch-allele-speci®c PCR This approach makes use of a primer
spanning the area adjacent to the mutation to introduce a new restriction
site either in the affected or the unaffected allele, allowing their clear
distinction after digestion. In this case (K5V186L), HK5p14 was used as
forward and HK5p18r (5¢-CCTTGTTCTGCTGCTCCAGGAACCG-
CG-3¢) as reverse PCR primer. HK5p18r introduces a C instead of a T
into the original sequence at codon 186 of KRT5, thus allowing the
identi®cation of the normal and mutant allele after digestion with HhaI
and analysis on 5% polyacrylamide gels (29:1) stained with ethidium
bromide.
Reverse transcriptase±PCR and cDNA analysis Epidermal sheets
(shave biopsies) of clinically uninvolved skin were taken from the gluteal
area of two affected patients (the father and grandfather) after in®ltrating
the skin with lidocaine±epinephrine. The biopsies were immediately
frozen. Total RNA was extracted according to the guanidium±phenol±
chloroform method (Chomczynski and Sacchi, 1987), with modi®cations
as described in ToÈrmaÈ et al (1993). After cDNA synthesis with an oligo
dT primer, part of the K5 transcript encoding for the ®rst 297 amino
acids was PCR ampli®ed using HK5p5 and HK5p12R (5¢-
CATCAGTGCATCAACCTTGGCCTC-3¢) as forward and reverse
primers, and sequenced in order to check for potential mis-splicing.
Site-directed mutagenesis Wild-type (WT) K5 and K14 cDNA was
cloned into the multiple cloning site of the pcDNA3 vector (Invitrogen),
which is designed for expression in mammalian host cells. Site-directed
mutagenesis was performed on plasmid DNA isolated from clones
containing the K5 and K14 WT cDNA inserts, according to the
QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA).
HK5pV186Lf (5¢-CTTCATCGACAAGTTGCGGTTCCTGGAGC-
AGC-3¢) was used as forward and the reverse complement
(HK5pV186Lr, 5¢-GCTGCTCCAGGAACCGCAACTTGTCGATG-
AAG-3¢) as reverse primer to introduce the V186L mutation into the
construct with K5 WT cDNA. To introduce the V133L mutation into
the K14 WT cDNA construct, HK14pV133Lf (5¢-GCCTCCTACCTG-
GACAAGTTGCGTGCTCTG-3¢) and HK14pV133Lr (5¢-CAGAGC-
ACGCAACTTGTCCAGGTAGGAGGC-3¢) were used as forward and
reverse primers, respectively. After transformation and plasmid DNA
isolation, constructs were sequenced in order to check that the mutation
was introduced.
Microinjection Lens epithelial cells (PE13300) were grown on
coverslips in Dulbecco's minimal Eagle's medium with 10% fetal bovine
serum and 0.5% gentamycin until 50±60% con¯uent. Subsequently, cells
were microinjected with an equimolar ratio of plasmid DNA (5 mg of
plasmid DNA in 10 ml of microinjection buffer), containing K5 WT plus
K14 WT cDNA, K5V186L plus K14 WT cDNA, and K5 WT plus
K14V133L cDNA. After microinjection, cells were returned to the
incubator and grown on coverslips until ®xation in methanol/acetone
(1 : 1) at the 16 h and 72 h time points. Cells were stained using a
rabbit polyclonal anti-K5 anti-serum (BL-18) as the primary antibody
and ¯uorescein isothiocyanate tagged goat-anti-rabbit serum as secondary
antibody. Cells were visualized by confocal microscopy.
Computer generated model of K5/K14 1A region In order to
visualize steric consequences of the two (K5 and K14) 1A:V18L
mutations, we constructed a three-dimensional model of human K5/K14
1A region heterodimer. The model is based on known crystal structure
of the homodimeric synthetic polypeptide corresponding to the leucine
zipper domain of the yeast Saccharomyces cerevisiae transcriptional activator
GCN4, deposited in PDB under code number 2ZTA. Modeling of 35
residues of the 1A helix (Conway and Parry, 1988) was performed with
WHATIF (Voorinholt et al, 1989) on an IBM PC compatible computer
with two Pentium II processors running LINUX. Further re®nement
and the molecular dynamics of K5/K14 1A region were carried out
using macromolecular simulation program CHARMM (Brooks et al,
1983). The co-ordinate ®le of the human K5/K14 1A region coiled-coil
can be downloaded from the following web site: http://www2.mf.uni-
lj.si/~stojan/stojan.html.
RESULTS
Mutation analysis Affected individuals from our EBS-K case are
heterozygous for a point mutation (GTG to TTG) altering codon
186 from valine to leucine (Fig 2A). This mutation was con®rmed
in all affected family members analyzed by mismatch-allele-speci®c
PCR followed by digestion with the restriction enzyme HhaI,
which cuts the normal but not the mutant allele. The PCR product
(560 bp) was shortened by 27 bp in the unaffected relative and in
50 control samples, whereas the affected individuals had only the
larger fragments present (Fig 2B). All of the KRT5 coding region
and the K14 hotspots (encoding helix domains 1A, L12, and 2B)
were sequenced but no additional changes were detected. The
mutation was not detected in 100 alleles from unaffected,
nonrelated individuals and is, therefore, unlikely to be a
polymorphism. As the mutation occurs at the exon side of the
splice site (the G/T change is actually the ®rst base in exon 2), any
potential mis-splicing had to be also excluded. Therefore, we
sequenced part of the cDNA encoding for the ®rst 297 amino acids
(exons 1, 2, 3, and part of exon 4) of K5 (data not shown). Except
for the mutation, no other changes were identi®ed to the transcript.
Cell culture analysis The identi®ed K5 mutation changes the
translated amino acid sequence from valine to leucine at position 18
of the 1A helix. Previously, we identi®ed a mutation in K14
(V133L)1 that also affects position 18 of the 1A helix; however, in
K14 this mutation produces a mild EBS-WC phenotype. We
looked to see whether the difference in the severity of the two
phenotypes found in these patients could be reproduced in a cell
culture system. Four mammalian expression constructs were made,
containing the WT and mutant (V18L) forms of keratins 5 and 14,
and these were then microinjected in different combinations into
PE13300 lens epithelial cells, which express only a vimentin
®lament network with minor quantities of synemin (which
colocalizes with vimentin), but no keratin. The expression of
Figure 2. Identi®cation and con®rmation of K5V186L mutation
in a patient with EBS-K. (A) The index case was found to have a
heterozygous point mutation in KRT5 at codon 186 (GTG to TTG,
lower panel), thus converting valine 186 into leucine (V186L) at position
18 in the 1A helix (1A:V18L). A normal sequence is shown in the upper
panel. (B) mismatch-allele-speci®cPCR followed by digestion with HhaI
was performed for the EBS-1 sample and 50 control samples. Gel
electrophoresis (5% polyacrylamide gel) revealed that the EBS-1 sample
(lane 2) gave two fragments, the uncut original (» 560 bp) and the
digested fragment (» 530 bp). Normal samples generated only the smaller
fragment (»530 bp) representing the normal allele (only two controls are
shown, lanes 3 and 4). The molecular weight marker (pBR322/HaeIII) is
in lane 1 (Std).
1Liovic M, Marks R, Komel R, Bowden PE: Novel mutations in the 1A
helical domain of K5 and K14 are involved in a mild epidermolysis bullosa
simplex (EBS) phenotype. J Invest Dermatol 109:405, 1997 (Abstr.)
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K5/K14 ®laments in these cells would thus require de novo keratin
®lament formation. Cells were ®xed and stained at different time
points (Fig 3). At the 16 h time point (Fig 3A±C), there was an
obvious delay in network assembly in the K5V186L/K14 WT
injected cells (Fig 3A), as well as a reduction in the ®lament
appearance (fragile, wispy ®laments) when compared with the K5
WT/K14V133L (Fig 3B) and the K5 WT/K14 WT (Fig 3C)
cells. The K5 WT/K14V133L expressing cells have well-formed
®laments by 16 h (Fig 3B), which have a greater tendency to
group in bundles than the web-like WT keratin ®laments
(Fig 3C). The bundling of the ®laments in mutant-expressing
cells is even more obvious by 72 h (Fig 3D, E compared with
WT, Fig 3F). The two mutations may also be indirectly affecting
the cell morphology as fewer large cells were seen among the
mutant-injected cells than among the K5 WT/K14 WT-injected
ones (Fig 3A±D).
Molecular modeling The comparison of amino acid
sequences between the GCN4 leucine zipper a-helix, the K5,
and K14 1A domain sequences (Table I) shows 26% identity;
however, it also reveals that all leucines in the 1A domain of
K5 and K14 lie at conserved, homologous positions as
compared with the GCN4 leucine zipper. In order to
construct a three-dimensional model of the K5/K14 1A
domain in its entirety, we ®rst elongated the GCN4 a-helix
by super-positioning its appropriate parts at the N-and C-
terminus. Two 59 residue long helices were thus obtained. In
the next step, we substituted all the differing residues (Table I)
in such a homodimer with the ones found in the human 1A
region of K5 and K14, respectively. This was done by using
the BLDPIR command in WHATIF followed by 20 cycles of
steepest descent (s.d.) re®nement with CHARMM, whereas the
N- and C-terminal amino acids were constrained (i.e., the
terminal residues from the GCN4 leucine zipper, which are left
after the introduction of 35 residues of K5/K14 1A region
sequence centrally into the 59 residue zipper chain). The
resulting structure was checked with the FSTCHK option in
the CHECK module, which gave a score similar to the
template GCN4 leucine zipper (2zta). Therefore, no additional
corrections were applied to the structure. The model was then
further evaluated by performing molecular dynamic calculations
on the 35 residue long coiled-coil. A box of 1554 water
molecules was added to the model structure. This was relaxed
by 200 cycles of s.d. re®nement with constrained protein,
followed by 10 ps dynamics at 300K. EWALD dynamics
calculations for 200 ps at 300 K without any constraints
resulted in a structure with the same, very good score
(FSTCHK option, CHECK module). The resulting model for
the WT molecule is shown in Fig 4. Note that the two salt
bridges between residues 1A:K17 and 1A:E22 of the opposite
strands (colored yellow, Fig 4), which lie just over the
mutation site(s), impose additional constraint on to the
resulting structure. The K5 and K14 1A region V18L
mutations were then introduced separately into the
heterodimer model with the mutate command of WHATIF,
and the entire molecular dynamic calculations were repeated.
Figure 3. PE13300 epithelial lens cells
microinjected with K5 and K14 constructs.
(A±C) Cells ®xed and stained (rabbit anti-K5,
BL18, as primary, and ¯uorescein isothiocyanate
tagged goat-anti-rabbit as secondary antibody) at
the 16 h postmicroinjection time point. (A) Cells
microinjected with K5V186L/K14 WT; (B) K5
WT/K14V133L and (C) K5 WT/K14 WT
cDNA constructs. (D±F) Cells ®xed and stained at
the 72 h postmicroinjection time point. (D) Cells
were microinjected with K5V186L/K14 WT; (E)
K5 WT/K14V133L; and (F) K5 WT/K14 WT
cDNA constructs. At 16 h postmicroinjection
there is a time delay in network assembly in
K5V186L/K14 WT cells (A), as well as ®laments
are thinner in appearance. Instead, the K5 WT/
K14V133L cells (B) have fully formed ®laments at
the same time point, but they tend more to
bundle in contrast to the web-like appearance of
the WT. The bundling is even more pronounced
at the 72 h time point, but in both cases where
cells express mutant keratins (D,E) compared with
the WT ones (F). Furthermore, the two 1A:V18L
mutations in K5 and K14 may indirectly also
affect the cell morphology. Scale bar : 10 mm.
Table I. Comparison of amino acid sequence of
heterodimeric synthetic polypeptide corresponding to the
leucine zipper of the yeast S. cerevisiae transcriptional
activator GCN4, with human K5 and K14 1A domaina
Keratin 5 RECIKTLNNKFASFIDKVRFLEQQNKVLDTKWTLL
Leucine
zipper
RMKQLEDKVEELLSKNYHLENEVARLKKLVG
Keratin 14 KVTMQNLNDRLASYLDKVRALEEANADLEVKIRDW
aIdentical residues are shown in bold. Sequence identity is 26%, but all leucines
(L) are at conserved, homologous positions within the three helices.
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The resulting models for these WT and mutant molecules are
shown in Fig 5. The degree of residue(s) displacement arising
after the introduction of the K5 or K14 1A:V18L mutation is
clearly visible. When substituting the valine with leucine, a
greater disruption of the coiled-coil is observed in K5 than in
K14 (see Fig 5). It is expected that such a greater disturbance
would lead to a greater instability within the K5/K14 ®lament,
accounting for the more severe clinical phenotype in the
individuals bearing this mutation.
DISCUSSION
Present knowledge of the role that different regions of keratin
proteins play in heterodimer formation, helix stabilization and
®lament assembly has been gathered from many sources including
in vivo/in vitro intermediate ®lament assembly studies (Hatzfeld and
Weber, 1990), functional studies (Coulombe et al, 1990; Coulombe
et al, 1991) and transgenic mouse experiments (Vassar et al, 1991).
Still, much about intermediate ®lament structure and function
remains unknown and very little information is yet available from
direct structural analysis (Herrmann et al, 2000).
Although disease severity in EBS was initially thought to be
primarily a function of the site of mutation, there is recent evidence
that mutations outside hotspot areas can affect protein stability and
cause abnormal phenotypes. It is becoming clear that the precise
phenotypic effects of speci®c mutations cannot easily be predicted.
Recently, a case was described (Shemanko et al, 1998) where the
same codon in K14 (M119) was affected by three different
mutations, independently resulting in the three major subtypes of
EBS. It was suggested that the location of the protein defect might
be of secondary importance to the nature of the amino acid change.
The K5V186L mutation is not the ®rst report of a 1A:V18L
change. Alterations in this residue have also been identi®ed in K12
(Irvine et al, 1997) and K14.1 Although the 1A:V18L mutation in
K14 is linked to a mild phenotype (EBS-WC), in the case of K5 it
causes more severe generalized blistering, diagnosed as EBS-K. The
V18L mutation is a conservative change (valine to leucine). It
involves no net change of charge, but there is a size difference
between the two molecules: valine is smaller than leucine, by one
CH2 group. As both amino acids have a branched structure,
substituting the smaller valine for the larger leucine could give rise
to steric hindrance, causing improper ®tting of the leucine into the
K5/K14 coiled-coil (see computer-generated model in Fig 5).
Furthermore, the constraint of the two salt bridges lying over the
top of the mutated residue (1A:V18) will increase the rigidity of the
coiled-coil and lead to bending in the mutated molecule. Although
in both cases (K5 and K14) the V18L mutation does affect its helix
directly, the local context leaves less space for a leucine in the case
of K5 (K5 1A:V18L), causing major bending and greater steric
interference with the surrounding residues. Local residue displace-
ment, and a consequent destabilization of the K5/K14 1A dimer,
would thus be predicted (Fig 5) to be greater for the mutation in
K5 than in K14 (where the leucine ®ts better into the coiled-coil).
This could be the reason why the K5 mutation results in a more
severe clinical phenotype (EBS-K) than the earlier reported K14
mutation (EBS-WC). Cell culture experiments also support this
analysis, as cells expressing the K5V186L construct show a time
delay in ®lament assembly when compared with the K14V133L (or
Figure 4. Space-®lling model of K5/K14 1A region. The N-
terminal end of the 1A domain is at the top of the ®gure; K5 on left,
K14 on right. Residues at ``d'' position are colored green. Asn25 at
position ``a'' in K5 1A is colored magenta, adjacent to the respective
residue in K14 in orange. The salt bridge between Glu22 of K5 1A (left
strand) and Lys17 of K14 1A (right strand) is in yellow, whereas both V18
residues (in K5 and K14 1A) are in red and lie immediately under the
salt bridge. The ®gure was generated with CHARMM and LIGHT
programs (see Brooks et al, 1983). Figure 5. Computer-generated model of K5/K14 1A regions as
helix representations. The K5 strand is in yellow and the K14 in blue.
The residues involved are shown as space-®lling in the end-on views
(below): WT (left), K5 1A:V18L mutation (center) and K14 1A:V18L
mutation (right). Both mutations, in conjunction with the two salt
bridges (see Fig 4), clearly produce major bending of the predicted
structure. The K5 mutant, however, causes far greater distortion of the
coiled-coil molecule than the corresponding K14 one, correlating with
the greater disease severity.
1Liovic M, Marks R, Komel R, Bowden PE: Novel mutations in the 1A
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to WT K5/K14) cells. The K5 mutation interferes both with the
normal rate of ®lament polymerization as well as with the
network's appearance.
Our results concur with the previous report by Shemanko et al,
1998, in suggesting that the position of the mutation within the
keratin protein can be of secondary importance to other factors.
We show that even a conservative substitution may or may not
have a major disruptive and pathogenic effect at a given point in the
sequence, depending on the local sequence context in that keratin.
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